Jaguar Health, Inc.
JAGX
$2.72
-$0.10-3.44%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.25M | 3.24M | 3.08M | 2.98M | 2.21M |
| Total Other Revenue | 25.00K | -- | -- | -- | -- |
| Total Revenue | 20.27M | 3.24M | 3.08M | 2.98M | 2.21M |
| Cost of Revenue | 1.16M | 2.20M | 532.00K | 527.00K | 515.00K |
| Gross Profit | 19.11M | 1.04M | 2.55M | 2.45M | 1.70M |
| SG&A Expenses | 5.00M | 7.16M | 6.13M | 7.19M | 7.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.09M | 23.68M | 10.32M | 10.99M | 11.64M |
| Operating Income | 10.18M | -20.44M | -7.24M | -8.01M | -9.42M |
| Income Before Tax | 8.72M | -23.19M | -9.65M | -10.56M | -10.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.72M | -23.19M | -9.65M | -10.56M | -10.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 126.00K | 132.00K | 146.00K | 153.00K | 132.00K |
| Net Income | 8.85M | -23.06M | -9.50M | -10.41M | -10.46M |
| EBIT | 10.18M | -20.44M | -7.24M | -8.01M | -9.42M |
| EBITDA | 10.66M | -19.97M | -6.76M | -7.53M | -8.94M |
| EPS Basic | 17.16 | -153.24 | -219.78 | -358.94 | -584.45 |
| Normalized Basic EPS | 11.58 | -91.66 | -136.10 | -183.08 | -362.52 |
| EPS Diluted | 17.16 | -153.24 | -219.78 | -358.94 | -584.45 |
| Normalized Diluted EPS | 11.58 | -91.66 | -136.10 | -183.08 | -362.52 |
| Average Basic Shares Outstanding | 515.80K | 151.40K | 43.20K | 29.00K | 17.90K |
| Average Diluted Shares Outstanding | 515.80K | 151.40K | 43.20K | 29.00K | 17.90K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |